Deciphering the determinants of recombinant protein expression across the human secretome

H Helen O. Masson (Department of Bioengineering, University of California) P Pablo Di Giusto (Department of Pediatrics, University of California) C Chih-Chung Kuo (Department of Bioengineering, University of California) M Magdalena Malm M Magnus Lundqvist (Department of Protein Science, KTH Royal Institute of Technology) Åsa Sievertsson (Department of Protein Science, KTH Royal Institute of Technology) A Anna Berling (Department of Protein Science, KTH Royal Institute of Technology) H Hanna Tegel (Department of Protein Science, SciLifeLab, KTH-Royal Institute of Technology) S Sophia Hober (Department of Protein Science, SciLifeLab, KTH-Royal Institute of Technology) M Mathias Uhlén (Department of Protein Science, SciLifeLab, KTH-Royal Institute of Technology) L Luigi Grassi (Cell Culture & Fermentation Sciences, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca) K Kimberly Robasky (Center for Molecular Medicine, Complex Carbohydrate Research Center, Department of Biochemistry and Molecular Biology, University of Georgia) C Chen-Lin Hsieh (Center for Molecular Medicine, Complex Carbohydrate Research Center, Department of Biochemistry and Molecular Biology, University of Georgia) D Diane Hatton (Cell Culture & Fermentation Sciences, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca) J Johan Rockberg N Nathan E. Lewis

Abstract

Protein secretion is an essential process of mammalian cells. In biomanufacturing, this process can be optimized to enhance production yields and biotherapeutic quality. While cell line engineering and bioprocess optimization have yielded high protein titers for some recombinant proteins, many remain difficult to express. Here, we investigated factors influencing protein expression in Chinese hamster ovary (CHO) cells, expressing 2,135 Human Secretome Project proteins. While the abundance of mRNA from recombinant proteins explained less than 1% of observed variation in secretion titers, analysis of 218 biochemical and biophysical descriptors uncovered intrinsic protein features that account for ~15% of secretion variability, pinpointing key drivers such as molecular weight, cysteine content, and N-linked glycosylation, and establishing a roadmap for rational design of difficult-to-express proteins. We subsequently analyzed RNA-Seq data from 95 CHO cell cultures, each expressing a distinct recombinant protein, spanning a wide range of titers. Host cell transcriptomic signatures showed strong correlations with titer, thereby providing insights into cellular processes that covary with expression. Cells failing to produce proteins exhibited increased ubiquitin-mediated proteasomal degradation, including ER-associated degradation; whereas high-producing cells demonstrated enhanced lipid metabolism and a stronger response to oxidative stress, suggesting these factors may support successful recombinant protein productions. Together, using this resource, we quantified the contributions of various protein and cellular factors that correlate with the expression of diverse recombinant human proteins in a heterologous host, thereby providing insights for next-generation CHO cell engineering.

Article Details

Volume / Issue Vol. 122, Issue 41
Published October 14, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (16)

H

Helen O. Masson

Department of Bioengineering, University of California

P

Pablo Di Giusto

Department of Pediatrics, University of California

C

Chih-Chung Kuo

Department of Bioengineering, University of California

M

Magdalena Malm

M

Magnus Lundqvist

Department of Protein Science, KTH Royal Institute of Technology

Åsa Sievertsson

Department of Protein Science, KTH Royal Institute of Technology

A

Anna Berling

Department of Protein Science, KTH Royal Institute of Technology

H

Hanna Tegel

Department of Protein Science, SciLifeLab, KTH-Royal Institute of Technology

S

Sophia Hober

Department of Protein Science, SciLifeLab, KTH-Royal Institute of Technology

M

Mathias Uhlén

Department of Protein Science, SciLifeLab, KTH-Royal Institute of Technology

L

Luigi Grassi

Cell Culture & Fermentation Sciences, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca

K

Kimberly Robasky

Center for Molecular Medicine, Complex Carbohydrate Research Center, Department of Biochemistry and Molecular Biology, University of Georgia

C

Chen-Lin Hsieh

Center for Molecular Medicine, Complex Carbohydrate Research Center, Department of Biochemistry and Molecular Biology, University of Georgia

D

Diane Hatton

Cell Culture & Fermentation Sciences, BioPharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca

J

Johan Rockberg

N

Nathan E. Lewis